Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
基于端粒酶的 GX301 癌症疫苗在转移性去势抵抗性前列腺癌患者中的应用：一项随机 II 期试验
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-021-03024-0
Gilberto Filaci #, Daniela Fenoglio #, Franco Nolè, Elisa Zanardi, Laura Tomasello, Massimo Aglietta, Gianluca Del Conte, Joan Carles, Rafael Morales-Barrera, Pamela Guglielmini, Giorgio Scagliotti, Alessio Signori, Alessia Parodi, Francesca Kalli, Giuseppina Astone, Francesca Ferrera, Tiziana Altos
